Baziaka Foteini Internist

Doctoral thesis

• 7/2009 Immunomodulatory effect of three-day continuous administration of clarithromycin for experimental sepsis due to multidrug-resistant Pseudomonas aeruginosa

Work Experience

Education Experience:

Clinical & Research Interest

Clinical Interest:

Research Interest:

• Septic Syndrome

• Options of Immunomodulatory treatment

Honors & Awards

• 2ο Award for best poster in the 9th Panhellenic Congress of Internal Medicine (October 2003, Athens) on «Ex vivo release of pro- inflammatory cytokines of blood monocytes of patients with sepsis: correlation to the initiation of symp-toms and to monocyte apoptosis. Kyriakopoulou M, Giamarellos -Bourboullis Ε, Raftogiannis M, Baziaka F, Plachouras D, Koussoulas V, Giamarellou H”.

• Second Award “Sotiris Papastamatis” in the 32nd Annual Panhellenic Congress, (May 2006, Athens) on «The effect of clarithromycin on the septic patient. Giamarellos-Bourboulis EJ, Routsi Ch, Raftogiannis M, Kollias S, Baziaka F, Zervakis D, Tsaganos T, Orphanos S, Armaganidis A, Roussos Ch, Giamarellou H”.

• Best Abstract Award in Sepsis 2009 (November 2009, Amsterdam) on “Effect of the novel influenza A (H1N1) virus in the human immune system. Antonopoulou A, Raftogiannis M, Baziaka F, Koutoukas P, Savva A, Kanni T, Georgitsi M, Pistiki A, Giamarellos-Bourboulis EJ

Recent Publications

• Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. Karaiskos I, Friberg LE, Pontikis K, Ioannidis K, Tsagkari V, Galani L, Kostakou E, Baziaka F, Paskalis C, Koutsoukou A, Giamarellou H. Antimicrob Agents Chemother. 2015 Dec;59(12):7240-8. doi: 10.1128/AAC.00554-15. Epub 2015 Sep 14.

• Association of autophagy-related 16-like 1 (ATG16L1) gene polymorphism with sepsis severity in patients with sepsis and ventilator-associated pneumonia. Savva A, Plantinga TS, Kotanidou A, Farcas M, Baziaka F, Raftogiannis M, Orfanos SE, Dimopoulos G, Netea MG, Giamarellos-Bourboulis EJ. Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1609-14. doi: 10.1007/s10096-014-2118-7. Epub 2014 May 3.

• Intravenous paracetamol as an antipyretic and analgesic medication: the sig-nificance of drug metabolism. 

• Giamarellos-Bourboulis EJ, Spyridaki A, Savva A, Georgitsi M, Tsaganos T, Mouktaroudi M, Raftogiannis M, Antonopoulou A, Papaziogas V, Baziaka F, Sereti K, Christopoulos P, Marioli A, Kanni T, Maravitsa P, Pantelidou I, Leventogiannis K, Tsiaoussis P, Lymberopoulou K, Koutelidakis IM. J Pharmacol Sci. 2014;124(2):144-52. Epub 2014 Jan 30.

• Effect of clarithromycin in patients with suspected Gram-negative sepsis: re-sults of a randomized controlled trial.

• Giamarellos-Bourboulis EJ, Mylona V, Antonopoulou A, Tsangaris I, Koutelidakis I, Marioli A, Raftogiannis M, Kopterides P, Lymberopoulou K, Mouktaroudi M, Pa-pageorgiou C, Papaziogas B, Georgopoulou AP, Tsaganos T, Papadomichelakis E, Gogos C, Ladas M, Savva A, Pelekanou A,Baziaka F, Koutoukas P, Kanni T, Spyridaki A, Maniatis N, Pelekanos N, Kotsaki A, Vaki I, Douzinas EE, Koratzanis G, Armaganidis A. J Antimicrob Chemother. 2014 Apr;69(4):1111-8. doi: 10.1093/jac/dkt475. Epub 2013 Nov 28.

• Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series. Karaiskos I, Galani L, Baziaka F, Katsouda E, Ioannidis I, Andreou A, Paskalis H, Giamarellou H. Int J Antimicrob Agents. 2013 May;41(5):480-3. doi: 10.1016/j.ijantimicag.2013.02.010. Epub 2013 Apr 6.

• Intraventricular and intrathecal colistin as the last therapeutic resort for the treatment of multidrug-resistant and extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis: a literature review. Karaiskos I, Galani L, Baziaka F, Giamarellou H. Int J Antimicrob Agents. 2013 Jun;41(6):499-508. doi: 10.1016/j.ijantimicag.2013.02.006. Epub 2013 Mar 16. Review

• Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence. Toufekoula C, Papadakis V, Tsaganos T, Routsi C, Orfanos SE, Kotanidou A, Carrer DP, Raftogiannis M, Baziaka F, Giamarellos-Bourboulis EJ. Crit Care. 2013 Jan 16;17(1):R6. doi: 10.1186/cc11930.

• Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae. Giamarellou H, Galani L, Baziaka F, Karaiskos I. Antimicrob Agents Chemother. 2013 May;57(5):2388-90. doi: 10.1128/AAC.02399-12. Epub 2013 Feb 25.

• Genetic polymorphisms within tumor necrosis factor gene promoter region: a role for susceptibility to ventilator-associated pneumonia. Kotsaki A, Raftogiannis M, Routsi C, Baziaka F, Kotanidou A, Antonopoulou A, Orfanos SE, Katsenos C, Koutoukas P, Plachouras D, Mandragos K, Giamarellos-Bourboulis EJ. Cytokine. 2012 Aug;59(2):358-63. doi: 10.1016/j.cyto.2012.04.040. Epub 2012 May 18.

• Effect of clarithromycin in inflammatory markers of patients with ventilator-associated pneumonia and sepsis caused by Gram-negative bacteria: results from a randomized clinical study. Spyridaki A, Raftogiannis M, Antonopoulou A, Tsaganos T, Routsi C, Baziaka F, Kara-gianni V, Mouktaroudi M, Koutoukas P, Pelekanou A, Kotanidou A, Orfanos SE, van der Meer JW, Netea MG, Giamarellos-Bourboulis EJ. Antimicrob Agents Chemother. 2012 Jul;56(7):3819-25. doi: 10.1128/AAC.05798-11. Epub 2012 May 7.